Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
STML

Stemline

$9.93

0.85 (9.36%)

21:15
01/15/19
01/15
21:15
01/15/19
21:15
Syndicate
Stemline 8.9M share Secondary priced at $9.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 16

    Jan

Monday
BGFV

Big 5 Sporting

$3.29

-0.01 (-0.30%)

, PLAY

Dave & Buster's

$50.84

-0.68 (-1.32%)

18:59
01/14/19
01/14
18:59
01/14/19
18:59
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Big 5…

BGFV

Big 5 Sporting

$3.29

-0.01 (-0.30%)

PLAY

Dave & Buster's

$50.84

-0.68 (-1.32%)

SSYS

Stratasys

$19.27

-0.45 (-2.28%)

ARRY

Array BioPharma

$17.07

-0.64 (-3.61%)

EXEL

Exelixis

$22.86

-0.89 (-3.75%)

GNW

Genworth

$4.80

(0.00%)

AGI

Alamos Gold

$3.81

-0.035 (-0.91%)

BGNE

BeiGene

$137.60

-6.54 (-4.54%)

XLRN

Acceleron

$46.39

-0.56 (-1.19%)

STML

Stemline

$9.08

-0.8 (-8.10%)

ALNY

Alnylam

$84.08

-5 (-5.61%)

PCG

PG&E

$8.37

-9.22 (-52.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 14

    Jan

  • 14

    Jan

  • 14

    Jan

  • 15

    Jan

  • 15

    Jan

  • 16

    Jan

  • 21

    Feb

  • 15

    Jan

  • 16

    Jan

  • 16

    Jan

STML

Stemline

$9.08

-0.8 (-8.10%)

16:35
01/14/19
01/14
16:35
01/14/19
16:35
Syndicate
Stemline files to sell 6.6M shares of common stock »

J.P. Morgan Securities is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Over a week ago
STML

Stemline

$10.10

0.04 (0.40%)

09:53
01/07/19
01/07
09:53
01/07/19
09:53
Hot Stocks
Stemline announces submission of European MAA for ELZONRIS »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 21

    Feb

STML

Stemline

$8.29

0.07 (0.85%)

08:26
12/26/18
12/26
08:26
12/26/18
08:26
Recommendations
Stemline analyst commentary at H.C. Wainwright »

Stemline boxed warning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

STML

Stemline

$8.29

0.07 (0.85%)

06:11
12/26/18
12/26
06:11
12/26/18
06:11
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

STML

Stemline

$8.25

-0.39 (-4.51%)

16:00
12/21/18
12/21
16:00
12/21/18
16:00
Conference/Events
Stemline to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

STML

Stemline

$8.34

-0.3 (-3.47%)

15:00
12/21/18
12/21
15:00
12/21/18
15:00
Hot Stocks
Stemline says Elzonris approval 'major step forward' for people with BPDCN »

Stemline Therapeutics,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

STML

Stemline

$8.42

-0.22 (-2.55%)

13:10
12/21/18
12/21
13:10
12/21/18
13:10
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline's Elzonris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

STML

Stemline

$8.58

-0.06 (-0.69%)

10:27
12/21/18
12/21
10:27
12/21/18
10:27
Hot Stocks
FDA approves Stemline's Elzonris infusion for BPDCN treatment »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.